Fernando
Lecanda Cordero
Profesional Investigador
University of Paris-Saclay
Gif-sur-Yvette, FranciaPublicacións en colaboración con investigadores/as de University of Paris-Saclay (4)
2020
-
Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma
Cancers, Vol. 12, Núm. 7, pp. 1-13
2019
-
CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
BMC Cancer, Vol. 19, Núm. 1
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2013
-
Zinc chelation: A metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
Cell Death and Disease, Vol. 4, Núm. 10